journal article·2020-07-08Open access

Mechanochemical Activation of Class-B G-Protein-Coupled Receptor upon Peptide–Ligand Binding

Cristina Lo Giudice, Haonan Zhang, Beili Wu, David Alsteens

Nano Letters· Volume 20· Issue 7

Abstract

Glucagon binding to the class-B G-protein-coupled glucagon receptor (GCGR) triggers the release of glucose from the liver during fasting. Recently, GCGR crystal structures have highlighted the conformation and molecular details of inactive and active receptor states. However, the dynamics of the conformational changes accompanying GCGR activation remains unclear. Here, we use multiplex force–distance curve-based atomic force microscopy (FD-based AFM) to probe in situ glucagon binding to individual GCGRs and monitor dynamically the transition to the active conformer. After a “dock” step, in which glucagon is partially bound to the GCGR extracellular domain, further interactions of the N-terminus with the transmembrane domain trigger an increase in the stiffness of the complex, adopting a highly stable and rigid “lock” conformer. This mechanotransduction is key for G-protein recruitment.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Receptor Mechanisms and Signaling · Neuropeptides and Animal Physiology · Monoclonal and Polyclonal Antibodies Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Louvain Institute of Biomolecular Science and Technology, Université Catholique de Louvain, Louvain-la-Neuve, Belgium

CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China

Funding

Universit? Catholique de Louvain · Fonds De La Recherche Scientifique - FNRS · European Molecular Biology Organization

References (28)

Show source-provided references
1. 10.1146/annurev-pharmtox-032112-13592310.1146/annurev-pharmtox-032112-135923 ↗
2. 10.1016/j.tips.2013.11.00110.1016/j.tips.2013.11.001 ↗
3. 10.1038/nature0814410.1038/nature08144 ↗
4. 10.1016/j.pharmthera.2012.05.00910.1016/j.pharmthera.2012.05.009 ↗
5. 10.1038/nature2515310.1038/nature25153 ↗
6. 10.1038/nature2236310.1038/nature22363 ↗
7. 10.1038/nature2239410.1038/nature22394 ↗
8. 10.1021/acs.chemrev.6b0017710.1021/acs.chemrev.6b00177 ↗
9. 10.1038/natrevmats.2017.810.1038/natrevmats.2017.8 ↗
10. 10.1007/s00216-019-02077-610.1007/s00216-019-02077-6 ↗
11. 10.1002/jmr.108110.1002/jmr.1081 ↗
12. 10.1038/nnano.2016.30310.1038/nnano.2016.303 ↗
13. 10.1038/ncomms985710.1038/ncomms9857 ↗
14. 10.1073/pnas.120294610910.1073/pnas.1202946109 ↗
15. 10.1038/nmeth.347910.1038/nmeth.3479 ↗
16. 10.1021/acs.nanolett.9b0267410.1021/acs.nanolett.9b02674 ↗
17. 10.1007/s00018-008-7479-610.1007/s00018-008-7479-6 ↗
18. 10.1210/endo-121-3-107610.1210/endo-121-3-1076 ↗
19. 10.1038/ncomms885910.1038/ncomms8859 ↗
20. 10.1124/pr.110.00430910.1124/pr.110.004309 ↗
21. 10.1016/j.phrs.2016.12.00610.1016/j.phrs.2016.12.006 ↗
22. 10.1073/pnas.190026111610.1073/pnas.1900261116 ↗
23. 10.1016/j.chembiol.2011.12.01310.1016/j.chembiol.2011.12.013 ↗
24. 10.1038/nature0964810.1038/nature09648 ↗
25. 10.1073/pnas.111408910810.1073/pnas.1114089108 ↗
26. 10.1073/pnas.84.12.408310.1073/pnas.84.12.4083 ↗
27. 10.1016/j.tibs.2009.02.00410.1016/j.tibs.2009.02.004 ↗
28. 10.1016/j.tips.2007.06.00310.1016/j.tips.2007.06.003 ↗